Repro Med Systems, Inc.(以 KORU Medical Systems 名義經營)主要在美國及國際上為門診輸液市場設計、製造及銷售便攜式醫療設備。公司總部位於紐約州切斯特。
財務指標
營業收入
2026-06-30
$12.04M
2026-03-31
$11.76M
2025-12-31
$10.89M
2025-09-30
$10.4M
營業支出
2026-06-30
$7.21M
2026-03-31
$7.89M
2025-12-31
$7.36M
2025-09-30
$7.13M
淨利潤
2026-06-30
$252.44K
2026-03-31
-$807.07K
2025-12-31
-$486.85K
2025-09-30
-$777.96K
淨利潤率
2026-06-30
2.09%
2026-03-31
-6.86%
2025-12-31
-4.46%
2025-09-30
-7.47%
每股收益
2026-06-30
$0.01
2026-03-31
$-0.01
2025-12-31
$0.01
2025-09-30
$-0.01
息稅折舊攤銷前利潤
2026-06-30
$468.27K
2026-03-31
-$609.54K
2025-12-31
-$302.99K
2025-09-30
-$573.63K
有效稅率
2026-06-30
2.24%
2026-03-31
--
2025-12-31
-0.97%
2025-09-30
0.01%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$12.04M
$11.76M
$10.89M
$10.4M
營業支出
$7.21M
$7.89M
$7.36M
$7.13M
淨利潤
$252.44K
-$807.07K
-$486.85K
-$777.96K
淨利潤率
2.09%
-6.86%
-4.46%
-7.47%
每股收益
$0.01
$-0.01
$0.01
$-0.01
息稅折舊攤銷前利潤
$468.27K
-$609.54K
-$302.99K
-$573.63K
有效稅率
2.24%
--
-0.97%
0.01%
常見問題
KRMD, which trades under the ticker KRMD, represents REPRO-MED Systems, Inc., commonly known as Repro Med Systems. The company is a medical device manufacturer that focuses on the development, manufacture, and sale of specialty infusion systems and related products. Its primary products are used for the delivery of medications and fluids in various clinical settings, including home infusion and hospital care. KRMD operates within the U.S. healthcare sector and serves a niche market of patients and healthcare providers.
The current price of KRMD stock fluctuates during market hours. To obtain the most accurate and up-to-date price, please refer to the live quote displayed on this page. The price you see reflects the latest trade and may change frequently based on supply and demand. For historical or intraday price information, you can also check the stock chart provided on the page.
Volatility measures how much KRMD's stock price moves over a given period. Small-cap medical device stocks like KRMD can experience significant price swings due to factors such as product announcements, regulatory decisions, or changes in financial performance. The stock's beta, which compares its volatility to the broader market, is available on the page. For specific volatility metrics, please refer to the latest KRMD data displayed on this page.
Evaluating KRMD's valuation involves reviewing metrics such as price-to-sales (P/S), price-to-earnings (P/E), and enterprise value-to-EBITDA, alongside comparisons to peers in the medical device industry. Because KRMD may not be consistently profitable, P/S or EV/Sales can be more informative. Additionally, assess the company's revenue growth, gross margins, and cash flow trends. All relevant valuation ratios are typically available on the stock detail page to help you form a comprehensive view.
KRMD is listed on the NASDAQ stock exchange, where it can be bought and sold through a licensed brokerage account. Trading occurs during regular market hours, typically from 9:30 a.m. to 4:00 p.m. Eastern Time, Monday through Friday, excluding market holidays. Some brokers also offer extended-hours trading sessions. To trade KRMD, you need to place an order through your broker's platform, specifying the number of shares and order type.
KRMD currently does not pay dividends to its shareholders. The company retains its earnings to reinvest in its business operations, research and development, and potential growth initiatives. As a result, there is no dividend yield or dividend history associated with KRMD. Investors seeking income may need to look at other stocks that distribute dividends, while those focused on growth may consider KRMD's reinvestment strategy as part of their evaluation.